About GenScript
GenScript is a company based in Piscataway (United States) founded in 2002.. GenScript has raised $15 million across 1 funding round from investors including Kleiner Perkins. The company has 5,570 employees as of December 31, 2024. GenScript has completed 1 acquisition, including CustomArray. GenScript operates in a competitive market with competitors including Abcam, Sino Biological, Stem Cell Technologies, Miltenyi Biotec and Devyser, among others.
- Headquarter Piscataway, United States
- Employees 5570 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Genscript Biotech Corporation
-
Annual Revenue
$602.59 M (USD)6.9as on Dec 31, 2024
-
Net Profit
$-271.68 M (USD)-182.2as on Dec 31, 2024
-
EBITDA
$75.84 M (USD)-4.38as on Dec 31, 2024
-
Total Equity Funding
$15 M (USD)
in 1 rounds
-
Latest Funding Round
$15 M (USD), Series A
Jun 23, 2009
- Investors
-
Employee Count
5570
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of GenScript
GenScript is a publicly listed company on the HKEX with ticker symbol 1548 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of GenScript
GenScript has successfully raised a total of $15M through 1 strategic funding round. The most recent funding activity was a Series A round of $15 million completed in June 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $15.0M
-
First Round
First Round
(23 Jun 2009)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2009 | Amount | Series A - GenScript | Valuation | Kleiner Perkins |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in GenScript
GenScript has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Kleiner Perkins. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in early-stage tech startups
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GenScript
GenScript has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include CustomArray. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Array-synthesized DNA capture probes are developed for targeted NGS sequencing.
|
2010 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - GenScript
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Genscript Comparisons
Competitors of GenScript
GenScript operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Sino Biological, Stem Cell Technologies, Miltenyi Biotec and Devyser, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biological reagents and antibodies are developed for life science research.
|
|
| domain | founded_year | HQ Location |
Reagents and kits are provided for clinical research applications.
|
|
| domain | founded_year | HQ Location |
Developer of cell culture media and ancillary reagents for life science research
|
|
| domain | founded_year | HQ Location |
Develops tools and products for research and clinical application
|
|
| domain | founded_year | HQ Location |
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Genscript
Frequently Asked Questions about GenScript
When was GenScript founded?
GenScript was founded in 2002 and raised its 1st funding round 7 years after it was founded.
Where is GenScript located?
GenScript is headquartered in Piscataway, United States. It is registered at Piscataway, New Jersey, United States.
Who is the current CEO of GenScript?
Frank Zhang is the current CEO of GenScript.
Is GenScript a funded company?
GenScript is a funded company, having raised a total of $15M across 1 funding round to date. The company's 1st funding round was a Series A of $15M, raised on Jun 23, 2009.
How many employees does GenScript have?
As of Dec 31, 2024, the latest employee count at GenScript is 5,570.
What is the annual revenue of GenScript?
Annual revenue of GenScript is $602.59M as on Dec 31, 2024.
What does GenScript do?
GenScript was founded in 2002 and is headquartered in Piscataway, United States. Operations focus on the life sciences sector, where a range of services is offered, including bio-reagents, bio-assays, lead optimization, and antibody drug development. Emphasis is placed on CRISPR reagents for genome editing. Bioinformatics tools, such as those for molecular biology, peptides, and proteins, are also included in the portfolio.
Who are the top competitors of GenScript?
GenScript's top competitors include Abcam, Sino Biological and Meridian Bioscience.
Is GenScript publicly traded?
Yes, GenScript is publicly traded on HKEX under the ticker symbol 1548.
How many acquisitions has GenScript made?
GenScript has made 1 acquisition, including CustomArray.
Who are GenScript's investors?
GenScript has 1 investor. Key investors include Kleiner Perkins.
What is GenScript's ticker symbol?
The ticker symbol of GenScript is 1548 on HKEX.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.